
|Articles|March 1, 2002
Trial compares responses to BTX-A, BTX-B
New Orleans - Results of a preliminary, double-blind, parallel group study demonstrate the efficacy of botulinum toxin type A (BTX-A, Botox) 20 units and botulinum toxin type B (BTX-B, Myobloc) 1,000 and 2,000 units for correcting deep glabellar furrows.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Quality of Life in CSU Shaped by More Than Skin Symptoms
4
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
5














